Sphingosine-1-phosphate reduces arterial thrombosis via enhanced endothelial thrombomodulin expression by S1PR1 signaling

1 September 2024 (12:00 - 12:30)

Organised by:

Video

Abstract

Slides

Sign in for access options

About the speaker

Doctor Marcel Benkhoff

University Hospital Duesseldorf, Duesseldorf (Germany)

4 More presentations in this session

Presentation thumbnail

The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

Mr T. Pirker (Christchurch, NZ)

Abstract Slides Video

Presentation thumbnail

Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia

Doctor S. Kuehne (Augsburg, DE)

Abstract Slides Video

Presentation thumbnail

Thrombin generation, fibrin clot permeation and lysis in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair: mitral fibrin study.

Doctor A. Siniarski (Krakow, PL)

Abstract Slides Video

Presentation thumbnail

Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation

Doctor S. Ministrini (Zurich, CH)

Abstract Slides Video

Access the full session

Session thumbnail

Platelets and thrombosis: novel experimental aspects

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET

You may be interested in

Congress Presentation

S1P receptor-1 signaling reduces arterial thrombosis by upregulation of endothelial thrombomodulin expression

Congress Presentation

Role of platelet derived sphingosine-1-phosphate in thrombosis and vascular ageing

Congress Presentation

Targeted modulation of sphingolipid signaling to inhibit the progression of aortic valve disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources